XML 33 R21.htm IDEA: XBRL DOCUMENT v3.25.2
Income Per Share and Stockholders' Equity
6 Months Ended
Jun. 30, 2025
Earnings Per Share And Stockholders Equity [Abstract]  
Income Per Share and Stockholders' Equity Income Per Share and Stockholders’ Equity
The calculations of basic and diluted income per share attributable to CBRE Group, Inc. stockholders are as follows (dollars in millions, except share and per share data):
Three Months Ended
June 30,
Six Months Ended
June 30,
2025202420252024
Basic Income Per Share
Net income attributable to CBRE Group, Inc. stockholders$215 $130 $378 $256 
Weighted average shares outstanding for basic income per share297,950,927 306,745,116 299,113,472 306,276,871 
Basic income per share attributable to CBRE Group, Inc. stockholders$0.72 $0.42 $1.26 $0.84 
Diluted Income Per Share
Net income attributable to CBRE Group, Inc. stockholders$215 $130 $378 $256 
Weighted average shares outstanding for basic income per share297,950,927 306,745,116 299,113,472 306,276,871 
Dilutive effect of contingently issuable shares2,057,495 1,290,095 2,341,781 1,992,169 
Weighted average shares outstanding for diluted income per share300,008,422 308,035,211 301,455,253 308,269,040 
Diluted income per share attributable to CBRE Group, Inc. stockholders$0.72 $0.42 $1.25 $0.83 
For the three and six months ended June 30, 2025, 639,807 and 412,610, respectively, of contingently issuable shares were excluded from the computation of diluted income per share because their inclusion would have had an anti-dilutive effect.
For the three and six months ended June 30, 2024, 983,949 and 693,772, respectively, of contingently issuable shares were excluded from the computation of diluted income per share because their inclusion would have had an anti-dilutive effect.
On November 21, 2024, our board of directors authorized an additional $5.0 billion to our existing $4.0 billion share repurchase program (as amended, the 2024 program) bringing the total authorized amount under the 2024 program to a total of $9.0 billion as of June 30, 2025. The board also extended the term of the 2024 program through December 31, 2029.
During the three months ended June 30, 2025, we repurchased 2,123,191 shares of our common stock with an average price of $120.43 per share for an aggregate of $256 million under the 2024 program. During the six months ended June 30, 2025, we repurchased 5,185,163 shares of our common stock with an average price of $127.82 per share for an aggregate of $663 million under the 2024 program. As of June 30, 2025, we had approximately $5.2 billion of capacity remaining under the 2024 program.
During the three and six months ended June 30, 2024, we repurchased 554,741 shares of our common stock with an average price of $87.25 per share for an aggregate of $48 million under the 2024 program.